Article Notes
This very large cohort study demonstrated an association between use of intermediate-duration NMBD and risk of postoperative desaturation and reintubation requiring ICU admission, and a similar association with these outcomes and neostigmine reversal.
Qualitative neuromuscular monitoring did not reduce this risk.
Study population was all patients at Massachusetts General Hospital undergoing general anaesthesia including a muscle relaxant over a 4 year period, and who were extubated at the end of the procedure.
Observation of pharyngeal function in 14 awake volunteers demonstrated pharyngeal dysfunction and increased aspiration risk at TOF ratios < 0.90.
“Partial neuromuscular paralysis caused by atracurium is associated with a four- to fivefold increase in the incidence of misdirected swallowing. … The majority of misdirected swallows resulted in penetration of bolus to the larynx.”
(Sundman in a 2000 follow-up study: The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium.)
Murphy et al. showed in this randomised, non-blinded trial that patients monitored with quantitative acceleromyography before extubation experienced less PORC, less desaturation below 90% (0% versus 21%) and less airway obstruction (0% versus 11%) during transport to the PACU.
Once in the PACU these patients also experienced less frequent, shorter duration and less severe hypoxic events.
This small (N=64) post-operative audit of children receiving muscle relaxants in an Australian tertiary paediatric hospital identified a 28% incidence of post-operative residual paralysis, measured immediately before extubation.
Worryingly, the incidence of residual paralysis was even higher in the subgroup reversed with neostigmine (38%), which the authors attribute to anaesthetists not waiting long enough after administration.
Severe residual paralysis (TOFR < 0.7) was observed in 7% of cases.
Only 23% of anaesthetists used intra-operative neuromuscular monitoring.
This is a great review to start with, providing a good overview of many of the myths regarding the use of neuromuscular blocking drugs that are still widely believed and practised by the global anaesthesia community.
All five of Fink & Hollman's 'myths' still hold today after reviewing the latest research in these areas.